CELADON SUBCO LIMITED

Active London

Other business support service activities n.e.c.

2 employees website.com
Life sciences and medical technology Other business support service activities n.e.c.
C

CELADON SUBCO LIMITED

Other business support service activities n.e.c.

Founded 12 Sept 2018 Active London, United Kingdom 2 employees website.com
Life sciences and medical technology Other business support service activities n.e.c.

Previous Company Names

SUMMERWAY SUBCO LIMITED 12 Sept 2018 — 20 Dec 2022
Accounts Due 31 Dec 2025 5 months overdue
Confirmation Submitted 17 Sept 2025 Next due 25 Sept 2026 4 months remaining
Net assets £73M £0 2023 year on year
Total assets £73M £0 2023 year on year
Total Liabilities £0
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

71-75 Shelton Street Covent Garden London WC2H 9JQ United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for CELADON SUBCO LIMITED (11565845), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 12 Sept 2018. Other business support service activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type audit-exemption-subsidiary
Next accounts 31 Dec 2024
Due by 31 Dec 2025 5 months overdue

Net Assets, Total Assets & Total Liabilities (2019–2023)

Cash in Bank

N/A

Net Assets

£73.36M

Total Liabilities

N/A

Turnover

N/A

Employees

2

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
2022
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 1,450,000 Shares £20k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
15 Jan 20211,450,000£20k£0.014

Officers

Officers

1 active 2 resigned
Status
Short, James GarethDirectorBritishEngland5821 Dec 2022Active

Shareholders

Shareholders (13)

Celadon Pharmaceuticals Limited
98.0%
80,000,001
Wakeley, Arthur
0.4%
300,000

Persons with Significant Control

Persons with Significant Control (1)

1 Active 4 Ceased
Active
Notified 12 Sept 2018
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Benjamin Howard Shaw

Ceased 27 Jan 2021

Ceased

Mark Kenneth Meakin Farmiloe

Ceased 27 Jan 2021

Ceased

Vinodka Murria

Ceased 11 Apr 2022

Ceased

Ian Alexander Anton

Ceased 27 Jan 2021

Ceased

Group Structure

Group Structure

CELADON SUBCO LIMITED Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
7 Apr 2026MortgageMortgage Create With Deed With Charge Number Charge Creation Date
7 Mar 2026GazetteGazette Filings Brought Up To Date
3 Mar 2026GazetteGazette Notice Compulsory
17 Sept 2025Persons With Significant ControlChange to Celadon Pharmaceuticals Plc as a person with significant control on 14 Aug 2025
17 Sept 2025Persons With Significant ControlChange to Celadon Pharmaceuticals Plc as a person with significant control on 16 Jun 2025
7 Apr 2026 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

7 Mar 2026 Gazette

Gazette Filings Brought Up To Date

3 Mar 2026 Gazette

Gazette Notice Compulsory

17 Sept 2025 Persons With Significant Control

Change to Celadon Pharmaceuticals Plc as a person with significant control on 14 Aug 2025

17 Sept 2025 Persons With Significant Control

Change to Celadon Pharmaceuticals Plc as a person with significant control on 16 Jun 2025

Recent Activity

Latest Activity

Mortgage Create With Deed With Charge Number Charge Creation Date

1 months ago on 7 Apr 2026

Gazette Filings Brought Up To Date

2 months ago on 7 Mar 2026

Gazette Notice Compulsory

2 months ago on 3 Mar 2026

Change to Celadon Pharmaceuticals Plc as a person with significant control on 14 Aug 2025

8 months ago on 17 Sept 2025

Change to Celadon Pharmaceuticals Plc as a person with significant control on 16 Jun 2025

8 months ago on 17 Sept 2025